Bonita Biotech (HK) Ltd - 09 Dec 2025 SCHEDULE 13G/A Report for Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS)

Filing Manager: Bonita Biotech (HK) Ltd
Reporting Manager: Biosion, Inc.
Security: Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value
Symbol: ACRS
Shares outstanding: 120,020,745 shares
Disclosed Ownership: 11,281,950 shares
Ownership: 9.4%
Form type: SCHEDULE 13G/A
Filing time: 09 Jan 2026, 08:59:56 UTC
Date of event: 09 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Biosion, Inc.	9.4%	11,281,950	11,281,950	0	/s/ MINGJIU CHEN	MINGJIU CHEN / CEO
Bonita Biotech (HK) Ltd	9.4%	11,281,950	11,281,950	0	/s/ MINGJIU CHEN	MINGJIU CHEN / Director